Laura Lee Sandler, Chief Operating Officer at Oruka Therapeutics, Inc. (ORKA), sold 5,000 shares at $62.58 ($319K) on 2026-05-01, disclosed to the SEC on 2026-05-01.
Scheduled sale ($319k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.58 | 2,200 | $138K | 43.1% |
| 2 | $64.15 | 1,800 | $115K | 36.2% |
| 3 | $65.10 | 300 | $20K | 6.1% |
| 4 | $66.06 | 400 | $26K | 8.3% |
| 5 | $67.16 | 200 | $13K | 4.2% |
| 6 | $68.48 | 100 |
| $7K |
| 2.1% |
| Total | $63.88 avg | 5,000 | $319K | 100% |
| Filing → |
| ORKA | SELL | 2026-06-15 | $42K | — | Filing → |
| ORKA | SELL | 2026-03-17 | $25K | — | Filing → |
| ORKA | SELL | 2026-03-02 | $168K | — | Filing → |